Initial Management of Acute Decompensated Heart Failure

Immediate Assessment and Stabilization

The American College of Cardiology recommends that patients admitted with congestive heart failure should receive intravenous loop diuretics within 60 minutes of presentation, starting at a dose equal to or exceeding their chronic oral daily dose (or 40 mg furosemide equivalent if diuretic-naïve), with early aggressive decongestion as the primary therapeutic goal 1
Upon admission, rapidly assess volume status and degree of congestion, adequacy of systemic perfusion, precipitating factors, new-onset versus chronic heart failure exacerbation, and ejection fraction status, as recommended by the American College of Cardiology 1
Administer supplemental oxygen if SpO2 <90% to relieve hypoxemia-related symptoms, but avoid hyperoxia, as suggested by the European Journal of Heart Failure 1, 3

The American College of Cardiology recommends starting IV loop diuretics immediately, with a dose equal to or exceeding the patient's chronic oral daily dose (or 40 mg furosemide equivalent if diuretic-naïve) 1
For diuretic-naïve patients, start with furosemide 40 mg IV bolus, as recommended by the American College of Cardiology 1
If decongestion targets are not met within 6-24 hours, intensify therapy by doubling the loop diuretic dose or adding combination diuretic therapy, as suggested by the American College of Cardiology and the European Heart Journal 1, 4

For patients with systolic BP >110 mmHg and severe symptomatic fluid overload, add IV vasodilators to diuretics, as recommended by the American College of Cardiology and Circulation 1, 5
IV nitroglycerin or nitroprusside can be beneficial for dyspnea relief and afterload reduction, as suggested by the American College of Cardiology and Circulation 1, 5

For patients with SBP <90 mmHg AND signs of hypoperfusion, hold diuretics until adequate perfusion is restored and consider IV inotropes to maintain systemic perfusion and end-organ function, as recommended by the American College of Cardiology and the European Heart Journal 1, 4
Levosimendan is preferred over dobutamine if beta-blockade is contributing to hypoperfusion, but avoid if SBP <85 mmHg unless combined with vasopressors, as suggested by the European Heart Journal 4

For patients already on ACE inhibitors/ARBs and beta-blockers, continue these medications unless hemodynamic instability or contraindications exist, as recommended by the American College of Cardiology and the European Journal of Heart Failure 1, 2, 6, 7
For GDMT-naïve patients with reduced ejection fraction, initiate ACE inhibitors/ARBs and beta-blockers before discharge, as recommended by the American College of Cardiology and the European Journal of Heart Failure 1, 2

Administer low molecular weight heparin to all patients without contraindications or existing anticoagulation to prevent deep venous thrombosis and pulmonary embolism, as recommended by the European Heart Journal 4
Obtain ECG and cardiac troponin immediately on all admissions, and consider urgent cardiac catheterization and revascularization for patients with acute myocardial ischemia and signs of inadequate perfusion, as recommended by the American College of Cardiology and Circulation 1, 5

Monitor fluid intake and output, daily weights, vital signs, clinical signs of perfusion and congestion, and daily electrolytes, BUN, and creatinine during IV diuretic use or medication titration, as recommended by the American College of Cardiology and Circulation 1, 5, 7

Consider pulmonary artery catheter placement for carefully selected patients with respiratory distress or impaired perfusion, persistent symptoms despite empiric therapy adjustments, or worsening renal function with therapy, as recommended by the American College of Cardiology, the European Journal of Heart Failure, and Circulation 1, 2, 5

Do not discharge patients who remain congested, and transition to oral diuretics only after adequate decongestion with careful dose adjustment, as recommended by the American College of Cardiology and the European Journal of Heart Failure 1, 2
Provide comprehensive written discharge instructions emphasizing diet, medications, activity level, follow-up appointments, daily weights, and symptom monitoring, as recommended by the American College of Cardiology and the European Journal of Heart Failure 1, 2
Arrange early follow-up within 72 hours of discharge, ideally with heart failure specialist or nurse practitioner, as recommended by the European Journal of Heart Failure 6